Vivani Medical Files 8-K
Ticker: VANI · Form: 8-K · Filed: Sep 9, 2025 · CIK: 1266806
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Vivani Medical filed an 8-K today, expect updates soon.
AI Summary
Vivani Medical, Inc. filed an 8-K on September 9, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about the nature of the disclosure.
Why It Matters
This 8-K filing indicates Vivani Medical is making a regulatory disclosure and submitting financial exhibits, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, with no immediate indication of significant negative events.
Key Players & Entities
- Vivani Medical, Inc. (company) — Registrant
- September 9, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 1350 S. Loop Road (address) — Principal executive offices
- Alameda, California (location) — Principal executive offices location
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the exact nature of the Regulation FD disclosure, only that it is being made.
What financial statements and exhibits are included in this filing?
The filing indicates that Financial Statements and Exhibits are included, but their specific content is not detailed in the provided text.
When was Vivani Medical, Inc. incorporated?
Vivani Medical, Inc. was incorporated in Delaware.
What is the principal executive office address for Vivani Medical, Inc.?
The principal executive office is located at 1350 S. Loop Road, Alameda, California 94502.
Does this 8-K filing mention any former company names or addresses?
The filing notes that the former company name was SECOND SIGHT MEDICAL PRODUCTS INC, with a date of name change on October 10, 2003.
Filing Stats: 585 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2025-09-09 16:21:48
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share VANI The Nasdaq Capital M
Filing Documents
- vani-20250909.htm (8-K) — 35KB
- ex991_1.htm (EX-99.1) — 23KB
- c078c0601c316492c622.jpg (GRAPHIC) — 72KB
- c0f12d2fa6424a0249a7.jpg (GRAPHIC) — 123KB
- c124febe786fa5133c02.jpg (GRAPHIC) — 81KB
- c253f8afb8218ca0a031.jpg (GRAPHIC) — 71KB
- c2761e59efeb25c02e55.jpg (GRAPHIC) — 111KB
- c3959a115a037cd4dae3.jpg (GRAPHIC) — 117KB
- c400a8126893fbc4378d.jpg (GRAPHIC) — 93KB
- c48468e3e6ec3c0f8587.jpg (GRAPHIC) — 112KB
- c4f84608627dfef942e4.jpg (GRAPHIC) — 96KB
- c5288a17314b4e16df19.jpg (GRAPHIC) — 72KB
- c54d1a69472444b220e2.jpg (GRAPHIC) — 93KB
- c699721dd50b17d1ca8a.jpg (GRAPHIC) — 220KB
- c737814f547ec126cc7f.jpg (GRAPHIC) — 123KB
- c75fbc787a46128c2662.jpg (GRAPHIC) — 95KB
- c86ccbb442531951552a.jpg (GRAPHIC) — 132KB
- c938500880abdfa02033.jpg (GRAPHIC) — 122KB
- c939b94e54ee245898ee.jpg (GRAPHIC) — 98KB
- caa1ecd24d7cfa80e9df.jpg (GRAPHIC) — 77KB
- cb76f07568a395aa67f7.jpg (GRAPHIC) — 64KB
- cc760ec991eb442ff1cc.jpg (GRAPHIC) — 114KB
- ccf64582aeec52d9eb3c.jpg (GRAPHIC) — 144KB
- cd9eec5dc4e5c77cb527.jpg (GRAPHIC) — 110KB
- cda3defd74bba5392ea6.jpg (GRAPHIC) — 104KB
- cdcbe6dcfb3cb6610fb1.jpg (GRAPHIC) — 64KB
- cee9d491ce2143a98795.jpg (GRAPHIC) — 112KB
- cfe1f527d19ac394e79b.jpg (GRAPHIC) — 95KB
- 0001753926-25-001443.txt ( ) — 3984KB
- vani-20250909_def.xml (EX-101.DEF) — 1KB
- vani-20250909_pre.xml (EX-101.PRE) — 29KB
- vani-20250909_cal.xml (EX-101.CAL) — 1KB
- vani-20250909_lab.xml (EX-101.LAB) — 42KB
- vani-20250909.xsd (EX-101.SCH) — 4KB
- vani-20250909_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. VIVANI MEDICAL, INC. Date: September 9 , 202 5 By: /s/ Donald Dwyer Name: Donald Dwyer Title: Chief Business Officer